In patients with lupus nephritis, anticardiolipin antibody is more significant than anti-β2 Glycoprotein I antibody in its ability to activate complement.
Autor: | Behera, Desabandhu1, Sutar, Shashi Bhusan2, Oram, Gouri3, Naik, Jitendra3 |
---|---|
Zdroj: | European Journal of Cardiovascular Medicine. 2024, Vol. 14 Issue 2, p899-902. 4p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |